Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Mundipharma A/S
A/S
Active
CVR 17981994
Frydenlundsvej 30, 2950
Vedbæk
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1994 · 31 years old
3 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Mundipharma A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
60M
45M
30M
15M
0M
2021: 48M
48M
2021
2022: 40M (-17% vs 2021)
40M
-17%
2022
2023: 36M (-10% vs 2022)
36M
-10%
2023
2024: 26M (-28% vs 2023)
26M
-28%
2024
2025: 26M (0% vs 2024)
26M
0%
2025
EBITDA
DKK millions
2M
2M
1M
1M
0M
2021: 2M
2M
2021
2022: 1M (-50% vs 2021)
1M
-50%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Revenue
25.912
26.430
35.938
40.102
48.453
Staff expenses
-3.575
-2.264
-1.951
-5.542
-8.951
EBITDA
777
793
1.131
1.255
1.510
Depreciation & amort.
-0
-0
-45
-43
-57
EBIT
777
793
1.086
1.212
1.454
Net financials
95
-115
64
-291
-284
Profit before tax
872
678
1.150
921
1.169
Tax
200
164
253
212
259
Net profit
672
514
897
709
910
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
51.353
53.921
48.751
61.135
85.666
Equity
38.165
37.493
36.979
49.837
49.128
Long-term debt
0
0
0
0
0
Short-term debt
13.188
16.428
11.772
11.298
36.538
Total debt
13.188
16.428
11.772
11.298
36.538
Financial ratios
5-year trend
EBITDA margin
3,0 %
This company
15,8 %
Market median
This company
Market median
81% below market
2021
2025
Equity ratio
74,3 %
This company
38,2 %
Market median
This company
Market median
95% above market
2021
2025
Return on equity
1,8 %
This company
18,4 %
Market median
This company
Market median
90% below market
2021
2025
Net profit margin
2,6 %
This company
8,1 %
Market median
This company
Market median
68% below market
2021
2025
Asset turnover
0,50×
This company
1,12×
Market median
This company
Market median
55% below market
2021
2025
Debt / equity
0,35×
This company
0,62×
Market median
This company
Market median
44% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Mundipharma A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
